If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £66.18m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Issue of Equity

2 Jun 2023 09:41

RNS Number : 5005B
Maven Income and Growth VCT 3 PLC
02 June 2023
 

Maven Income and Growth VCT 3 PLC (the Company)

 

Issue of Equity

 

On 7 October 2022, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £5 million, with an over-allotment facility for up to a further £5 million (the Offer).

 

Pursuant to the Offer, £819,220 of valid applications were received in the period from 7 October 2022 up to 12 noon on 26 May 2023 in respect of the 2023/2024 tax year. This is the first and final allotment in respect of the 2023/2024 tax year and, as a result, the Company has issued and allotted 1,441,593 new Ordinary Shares on 2 June 2023. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which these shares were issued were in the range of 56.27p to 57.18p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 115,358,633. Therefore, the total number of voting rights in the Company is 115,358,633.

 

The total funds raised by the Company for the 2022/2023 and the 2023/2024 tax years is £6,752,600.

 

In respect of this allotment, an application will be made by the Company to the FCA and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective, and dealings will commence on or around 6 June 2023.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

2 June 2023

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFVTRAIFIIV
Date   Source Headline
5th Apr 20136:14 pmRNSIssue of Equity
5th Apr 20134:54 pmRNSTransaction in Own Shares
5th Apr 201312:17 pmRNSDirector/PDMR Shareholding
4th Apr 20135:35 pmRNSDirector/PDMR connected person shareholding
4th Apr 20134:07 pmRNSTransaction in Own Shares
27th Mar 20137:00 amRNSAnnual Financial Report
5th Mar 20134:13 pmRNSIssue of Equity
11th Feb 20135:42 pmRNSOffer for Subscription - Update
23rd Jan 20135:03 pmRNSIssue of Equity
16th Nov 20123:02 pmRNSTransaction in Own Shares
15th Nov 20125:01 pmRNSTransaction in Own Shares
14th Nov 20123:21 pmRNSTransaction in Own Shares
5th Nov 20125:01 pmRNSIssue of Equity
30th Oct 20127:00 amRNSTransaction in Own Shares
30th Oct 20127:00 amRNSTransaction in Own Shares
25th Oct 20127:00 amRNSDirector/PDMR Shareholding
23rd Oct 201210:02 amRNSDirector/PDMR Shareholding
19th Oct 20122:15 pmRNSInterim Management Statement
17th Oct 20125:20 pmRNSResult of General Meeting
21st Sep 20122:17 pmRNSCirc re. Enhanced Buyback Scheme
13th Sep 20121:03 pmRNSStatement re Enhanced Buyback Scheme
23rd Aug 20126:30 pmRNSDirector/PDMR Shareholding
16th Aug 20125:00 pmRNSDirector/PDMR Shareholding
6th Aug 201212:00 pmRNSTransaction in Own Shares
13th Jul 20124:59 pmRNSHalf Yearly Report
31st May 20125:14 pmRNSTransaction in Own Shares
25th May 201211:56 amRNSTransaction in Own Shares
25th May 201211:54 amRNSTransaction in Own Shares
23rd May 20122:29 pmRNSTransaction in Own Shares
22nd May 20125:12 pmRNSTransaction in Own Shares
4th May 20125:22 pmRNSDirector/PDMR Shareholding
4th May 201212:18 pmRNSAnnual Information Update
3rd May 201211:47 amRNSResult of AGM
1st May 20122:59 pmRNSInterim Management Statement
20th Apr 20121:31 pmRNSIssue of Equity
20th Apr 20121:09 pmRNSIssue of Equity
10th Apr 20129:48 amRNSIssue of Equity
27th Mar 201211:03 amRNSTransaction in Own Shares
23rd Mar 20124:55 pmRNSTransaction in Own Shares
20th Mar 201210:56 amRNSTransaction in Own Shares
19th Mar 201212:23 pmRNSTransaction in Own Shares
16th Mar 20124:43 pmRNSDirector/PDMR Shareholding
16th Mar 20123:05 pmRNSTransaction in Own Shares
13th Mar 201212:10 pmRNSAnnual Financial Report
8th Mar 201210:57 amRNSDirector/PDMR Shareholding
2nd Mar 20129:37 amRNSIssue of Equity
7th Dec 20114:22 pmRNSIssue of Equity
2nd Dec 20112:56 pmRNSTransaction in Own Shares
30th Nov 20114:26 pmRNSTransaction in Own Shares
28th Nov 20112:44 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.